Interim analysis of the Daliah trial - a randomized controlled phase iii clinical trial Comparing recombinant interferon alpha-2 vs. Hydroxyurea in MPN patients.

Trine Alma Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, Ole Weiss Bjerrum, Mette Brabrand, Daniel El Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben A Kruse, Hans Torben Mourits-Andersen, Peter Møller, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Henriette Skov, Jesper Stentoft, Jørn Starklint, Karin de Stricker, Mads Thomassen, Thomas Stauffer LarsenHans Carl Hasselbalch

Research output: Contribution to journalConference abstract in journalResearchpeer-review

98 Downloads (Pure)
Original languageEnglish
Article numberS131
JournalHemaSphere
Volume2
Issue numberS1
Pages (from-to)18-19
DOIs
Publication statusPublished - 15. Jun 2018
EventEuropean Hematology Association 23rd congress EHA 2018 - Stockholm , Sweden
Duration: 14. Jun 201817. Jun 2018

Conference

ConferenceEuropean Hematology Association 23rd congress EHA 2018
Country/TerritorySweden
CityStockholm
Period14/06/201817/06/2018

Cite this